Physician profile
Lorraine Harris
NPI 1487828018
$4,127.27
in general payments reported to CMS, 2019-2025
24 companies · $1,432 in 2025
The $1,432 reported for 2025 was more than what 98% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $767 · 2022: $689 · 2023: $602 · 2024: $637 · 2025: $1,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,472 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,472.04 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $925.00 | 2021-2022 | |
| Astellas Pharma US INC | $696.46 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $318.23 | 2024-2025 | |
| Abbvie INC. | $269.28 | 2021-2022 | |
| Amgen INC. | $226.00 | 2021 | |
| Sumitomo Pharma America, INC. | $224.24 | 2023-2025 | Myfembree, Gemtesa |
| Gilead Sciences, INC. | $221.79 | 2024-2025 | Yeztugo, Epclusa |
| Exact Sciences Corporation | $218.29 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $213.12 | 2023-2025 | Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $155.31 | 2023-2025 | |
| Lilly USA, LLC | $124.50 | 2025 | Zepbound |
| Exeltis, USA INC. | $112.10 | 2021-2025 | Slynd |
| Biogen, INC. | $101.63 | 2025 | Zurzuvae |
| Abiomed | $81.10 | 2024-2025 | Impella |
| Merck Sharp & Dohme LLC | $61.03 | 2024-2025 | Gardasil 9, Gardasil |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $44.71 | 2024-2025 | Paragard T 380a |
| Gynesonics, INC. | $22.63 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $21.59 | 2024 | |
| Hologic Sales and Service, LLC | $19.32 | 2025 | Aptima |
| Boston Scientific Corporation | $15.83 | 2023 | |
| Sage Therapeutics, LLC | $15.31 | 2025 | Zurzuvae |
| Eagle Pharmaceuticals, INC. | $13.88 | 2023 | |
| Millicent US INC | $13.64 | 2025 | Intrarosa, Femring |
| Avion Pharmaceuticals | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorraine Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.